92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro

Journal of Dental Research

Volumn 78, Issue 7, 1999, Pages 1354-1361

  Pickett, K L ^a,d   Harber, G J ^a,c   Decarlo, A A ^a,b   Louis, P ^a   Shaneyfelt, S ^a,c   Windsor, L J ^a,c   Bodden, M K ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d NONE   (United States)

Author keywords

Collagenase activity; Gelatinases A and B; Immunocytochemistry; Oral cancer

Indexed keywords

ANTIBODY; COLLAGEN; COLLAGENASE; DIAGNOSTIC AGENT; GELATINASE; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; METALLOPROTEINASE; RADIOPHARMACEUTICAL AGENT; STROMELYSIN; TRITIUM;

ARTICLE; BASEMENT MEMBRANE; BIOSYNTHESIS; CANCER INVASION; COMPARATIVE STUDY; DISEASE COURSE; ENZYMOLOGY; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METASTASIS; MOUTH TUMOR; NEUTROPHIL; PATHOLOGY; SQUAMOUS CELL CARCINOMA; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANTIBODIES; BASEMENT MEMBRANE; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; COLLAGEN; COLLAGENASES; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FIBROBLASTS; GELATINASES; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEUTROPHILS; RADIOPHARMACEUTICALS; TRITIUM;

EID: 0033278150     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/00220345990780071001     Document Type: Article

References (33)

1. Aimes RT, Quigley JP (1995). Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4 and 1/4-length fragments. J Biol Chem 270:5872-5876.
2. Ballin M, Gomez DE, Sinha CC, Thorgeirsson UP (1988). Rns oncogene mediated induction of a 92 kDa metalloproteinase: strong correlation with the malignant phenotype. Biochem Biophys Res Commun 154:832-838.
3. Bernhard EJ, Muschel RJ, Hughes EN (1990). Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res 50:3872-3877.
4. Birkedal-Hansen H (1987). Catabolism and turnover of collagens: collagenases. Meth Enzymol 144:140-171.
5. Birkedal-Hansen H, Birkedal-Hansen B, Windsor LJ, Lin HY, Taylor RE, Moore WG (1989). Use of inhibitory (anti-catalytic) antibodies to study extracellular proteolysis. Immunol Invest 18:211-224.
6. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al (1993). Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4:197-250.
7. Cotran RS, Kumar V, Robbins SL (1989). Cellular injury and adaption. Inflammation and repair. In: Pathologic basis of disease. Cotran RS, Kumar V, Robbins SL, editors. Philadelphia: W.B. Saunders Company, pp. 1-87.
8. Crabbe T, O'Connell JP, Smith BJ, Docherty AJ (1994). Reciprocated matrix metelloproteinase activation: a process performed by interstitial collagenase and progelatinase A. Biochemistry 33:14419-14425.
9. Freije JM, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, et al. (1994). Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 269:16766-16773.
10. Fridman R, Toth M, Pena D, Mobashery S (1995). Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 55:2548-2555.
11. Fullmer HM, Gibson WA, Lazarus GS, Bladen HA, Whedon KA (1969). The origin of collagenase in periodontal tissues of man. J Dent Res 48:646-651.
12. Gross J, Lapiere CM (1962). Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sei USA 48:147-155.
13. Henson DE (1996). Loss of p53-immunostaining intensity in breast cancer. J Natl Cancer last 88:1015-1016.
14. Jacobs TW, Prioleau JE, Stillman IE, Schnitt SJ (1996). Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer lust 88:1054-1059.
15. Kubota S, Mitsudomi T,Yamada Y (1991). Invasive human fibrosarcoma DNA mediated induction of a 92 kDa gelatinase/type IV collagenase leads to an invasive phenotype. Biochem Biophys Res Commun 181:1539-1547.
16. Kusukawa J, Sasaguri Y, Shima I, Kameyama T, Morimatsu M (1993). Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. Am J ClinPathol 99:18-23.
17. Liotta LA, Steeg PS, Stetler-Stevenson WG (1991). Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64:327-336.
18. Lyons JG, Birkedal-Hansen B, Moore WG, O'Grady RL, BirkedalHansen H (1991). Characteristics of a 95-kDa matrix metalloproteinase produced by mammary carcinoma cells. Biochem 30:1449-1456.
19. Monteagudo C, Merino MJ, San-Juan J, Liotta LA, StetlerStevenson WG (1990). Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am J Pathol 136:585-592.
20. Murphy G, Cocket MI, Stephens PE, Smith BJ, Docherty AJP (1987). Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochem J 248:265-268.
21. Murphy G, Willenbrock F, Crabbe T, O'Shea M, Ward R, Atkinson S, et al. (1995). Regulation of matrix metalloproteinase activity. Ann NY Acad Sei 23:31-35.
22. Poulsom R, Pignatelli M, Stetler-Stevenson WG, Liotta LA, Wright PA, Jeffrey RE, et al. (1992). Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 141:389-396.
23. Sang QA, Douglas DA (1996). Computational sequence analysis of matrix metalloproteinases. J Prot Chem 15:137-160.
24. Sang QA, Bodden MK, Windsor LJ (1996). Activation of human progelatinase A by collagenase and matrilysin: activation of procollagenase by matrilysin. J Prot Chem 15:243-253.
25. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, et al. (1994). A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:61-65.
26. Simmer JP, Fukae M, Tanabe T, Yamakoshi Y, Uchida T, Xue J, et al. (1998). Purification, characterization, and cloning of enamel matrix serine proteinase 1. J Dent Res 77:377-386.
27. Stearns ME, Wang M (1993). Type IV collagenase (Mr 72,000) expression in human prostate: benign and malignant tissue. Cancer Res 53:878-883.
28. Stetler-Stevenson WG (1990). Type IV collagenases in tumor invasion and metastasis. Cancer Metas Rev 9:289-303.
29. Stetler-Stevenson WG, Ray JM (1994). Genetic modulation of TIMP-2 in human melanoma cells: modulation of the invasive phenotype. Ann NY Acad Sei 732:233-247.
30. Stetler-Stevenson WG, Liotta LA, Kleiner DE Jr (1993). Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 7:1434-1441.
31. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI (1995). Mechanism of cell surface activation of 72-kDa type IV collagenase. J Bid Chem 270:5331-5338.
32. Windsor LJ, Grenett H, Birkedal-Hansen B, Bodden MK, Engler JA, Birkedal-Hansen H (1993). Cell type-specific regulation of SL-1 and SL-2 genes, induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbolesters. J Biol Chem 268:17341-17347.
33. Windsor LJ, Steele DL, Leblanc SB, Taylor KB (1997). Catalytic domain comparisons of human fibroblast-type collagenase, stromelysin-1, and matrilysin. Biochim Biophys Ada 1334:261-272.